Table 2. Treatment and dose-limiting toxicities for each dose level (all cycles).
Tremelimumab, mg kg−1 | PF-3512676, mg kg−1 | Patients, n | Dose-limiting toxicities, n |
---|---|---|---|
6 |
0.05 |
3 |
0 |
10 |
0.05 |
6 |
1 |
15 |
0.05 |
6 |
2 |
10 |
0.10 |
3 |
1 |
10 | 0.15 | 3 | 2 |